Perspectives in Anti-Inflammatory Therapies in Sepsis

  • Jean-François Dhainaut
  • Nathalie Marin
  • Alain Cariou
Part of the Perspectives on Critical Care Infectious Diseases book series (CCID, volume 2)


Sepsis represents a systemic reaction to a microbial infection. The reaction is triggered by bacterial toxins or by components of microbial cell wall fragments. Innate immunity with its germ-line encoded receptors for the recognition of microbial pathogens, represents a phylogenetically ancient defense against micro-organisms. Acquired immunity allows the development of memory of previously encountered pathogens, and results from the generation of a large repertoire of antigen-recognizing receptors.


Nitric Oxide Septic Shock Severe Sepsis Migration Inhibitory Factor Disseminate Intravascular Coagulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abraham E. Why immunomodulatory therapies have not worked in sepsis? Intensive Care Med 1999;25:556–566.PubMedCrossRefGoogle Scholar
  2. 2.
    Sevransky JE, Natanson C. An analysis of clinical trials of mediator-specific anti-inflammatory agents. Sepsis 1999;3:11–19.CrossRefGoogle Scholar
  3. 3.
    Wheeler AP, Bernard GR. Treating patients with severe sepsis N Engl J Med 1999;340:207–214.PubMedCrossRefGoogle Scholar
  4. 4.
    Meduri GU. An historical review of glucocortcoid treatment in sepsis. Sepsis 1999;3:21–38.CrossRefGoogle Scholar
  5. 5.
    Llewelyn M, Cohen J. Anti-endotoxin antibodies in sepsis: a critical evaluation. Sepsis 1999;3:39–45.CrossRefGoogle Scholar
  6. 6.
    Giroir BP, Quint PA, Barton P, Kirsh EA, Kitchen L, Goldstein B, Nelson BJ, Wedel NJ, Carroll SF, Scannon PJ. Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis. Lancet 1997;350:1439–1443.PubMedCrossRefGoogle Scholar
  7. 7.
    Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, Cheval C, Monchi M, Reboul JL, Riche F, Leleu G, Arbibe L, Mignon A, Delpech M, Dhainaut JF. Association of TNF2, a TNF-α promoter polymorphism, with septic shock susceptibility and mortality. JAMA 1999;282:561–568.PubMedCrossRefGoogle Scholar
  8. 8.
    Cohen J, Heumann D, Glauser MP. Do monoclonal antibodies and anticytokines still have a future in infectious disease. Am J Med 1995;99:45S–51S.PubMedCrossRefGoogle Scholar
  9. 9.
    Chaudry IH. Sepsis: lessons learned in the last century and future directions. Arch Surg 1999; 134:922–929.PubMedCrossRefGoogle Scholar
  10. 10.
    Opal SM, Cohen J. Are there fundamental differences of clinical relevance between gram-positive and gram-negative bacterial sepsis? Crit Care Med 1999;27:1608–1616.PubMedCrossRefGoogle Scholar
  11. 11.
    Vincent JL. Search for effective immunomodulating strategies against sepsis. Lancet 1999;351:922–923.Google Scholar
  12. 12.
    Sprung C, Finch RG, Thijs LG, Glauser MP. International sepsis trial (INTERSEPT):role and impact of a clinical evaluation committee. Crit Care Med 1996;24:1441–1447.PubMedCrossRefGoogle Scholar
  13. 13.
    Esmon CT. New potential therapeutic modalities: aPC. Sepsis 1999;3:161–172.CrossRefGoogle Scholar
  14. 14.
    Annane D, Seville V, Troche G, Raphael JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000;283:1038–1045.PubMedCrossRefGoogle Scholar
  15. 15.
    Cohen J. Adjunctive therapy in sepsis; a critical analysis of the clinical programme. Br Med Bull 1999;55:212–225.PubMedCrossRefGoogle Scholar
  16. 16.
    Modlin RL, Brightbill HD, Godowski PJ. The toll of innate immunity on microbial pathogens. N Engl J Med 1999;340:1834–1835.PubMedCrossRefGoogle Scholar
  17. 17.
    Rogiers P. Hemofiltration treatment for sepsis: is it time for a controlled trial? Kidney Inter 1999;56:S99–S103.CrossRefGoogle Scholar
  18. 18.
    Tetta C, Bellomo R, Brendolan A, Piccinni P, Digito A, Dan M, Irone M, Lonnemann G, Moscato D, Buades J, La Greca G, Ronco C. Use of adsorptive mechanisms in continuous renal replacement therapies in the critically ill. Kidney Inter 1999;56:S15-S19.Google Scholar
  19. 19.
    Liaudet L, Soriano FG, Szabo C. Biology of nitric oxide signaling. Crit Care Med 2000;28:N37–N52.PubMedCrossRefGoogle Scholar
  20. 20.
    Thiemermann C. The use of selective inhibitors of inducible nitric oxide synthase in septic shock. Sepsis 1998; 1:123–130.CrossRefGoogle Scholar
  21. 21.
    Fischer SR, Bone HG, Harada M, Jourdain M, Traber D. Nitric oxide scavengers in sepsis. Sepsis 1998;1:137–144.CrossRefGoogle Scholar
  22. 22.
    Creasey AA. New potential therapeutic modalities; tissue factor pathway inhibitor. Sepsis 1999;3:173–182.CrossRefGoogle Scholar
  23. 23.
    Opal SM, Thijs LG. New potential therapeutic modalities; antithrombin III. Sepsis 1999;3:153–160.CrossRefGoogle Scholar
  24. 24.
    Esmon CT. New potential therapeutic modalities; a PC. Sepsis 1999;3:161–172.CrossRefGoogle Scholar
  25. 25.
    Czermak BJ, Sarma V, Pierson CL, Warner RL et al. Protective effects of C5a blockade in sepsis. Nature Med 1999;5:788–792.PubMedCrossRefGoogle Scholar
  26. 26.
    Calandra T, Echtenacher B, Le Roy D, Pugin J, Metz CN, Hultner L, Heumann D, Mannel D, Bucala R, Glauser MP. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nature 2000;6:164–170.CrossRefGoogle Scholar
  27. 27.
    Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285;248–251.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Jean-François Dhainaut
    • 1
  • Nathalie Marin
    • 1
  • Alain Cariou
    • 1
  1. 1.Medical Intensive Care UnitCochin Port-Royal University HospitalFrance

Personalised recommendations